MoneyWorks4Me

Granules India informs about disclosure

23 Jul 2022 Evaluate

Granules India has informed that the US FDA has completed an inspection of the facility of Granules Pharmaceuticals, Inc., a wholly-owned foreign subsidiary of the Company located in Chantilly, Virginia, the USA on 22nd July 2022 with six (6) observations. Granules Pharmaceuticals, Inc. will respond to these observations within the stipulated time period.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..